Millennium Management’s Standard BioTools LAB Stock Holding History

Millennium Management’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-125,000	Closed	-$490K	–	7207
2021 Q4	$490K	Buy	125,000 +25,000	+25%	+$117K	﹤0.01%	5061
2021 Q3	$659K	Buy	+100,000	New	+$658K	﹤0.01%	5083
2016 Q1	–	Sell	-100,000	Closed	-$1.08M	–	3482
2015 Q4	$1.08M	Hold	100,000	–	–	﹤0.01%	2266
2015 Q3	$811K	Buy	+100,000	New	+$1.57M	﹤0.01%	2401

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Millennium Management's LAB Position: Q1 2026 in Review

Millennium Management reduced its Standard BioTools (LAB) stake by 38% in Q1 2026, selling an estimated $1.56M and leaving 2,102,015 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #3903.

Millennium Management first reported a position in LAB in Q2 2013 and has held it in 51 quarters since. The position peaked at $39M in Q1 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

Millennium Management held 2,102,015 shares of Standard BioTools worth $1.93M as of Q1 2026.
Millennium Management sold 1,285,413 Standard BioTools shares in Q1 2026, an estimated $1.56M.
Standard BioTools made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3903 holding.
Millennium Management first reported a position in Standard BioTools in Q2 2013 and has held it in 51 quarters since.
Millennium Management's Standard BioTools position peaked at $39M in Q1 2024.
155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.